Sionna Therapeutics, Inc. SION
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-02-07
Sionna Therapeutics, Inc. statistics & valuation
Market cap$1.9B
P / B6.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -23.1% | -33.2% |
| Return on equity | -24.5% | 37.7% |
| Current ratio | 20.61 | 14.49 |
Source: SEC EDGAR filings · CIK 0002036042 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.